Literature DB >> 19913314

The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion.

Borja Ibanez1, Giovanni Cimmino, Susanna Prat-González, Gemma Vilahur, Randolph Hutter, Mario J García, Valentin Fuster, Javier Sanz, Lina Badimon, Juan J Badimon.   

Abstract

BACKGROUND: Myocardial infarct size is a strong predictor of cardiovascular events. Intravenous metoprolol before coronary reperfusion has been shown to reduce infarct size; however, it is unknown whether oral metoprolol initiated early after reperfusion, as clinical guidelines recommend, is similarly cardioprotective. We compared the extent of myocardial salvage associated with intravenous pre-reperfusion-metoprolol administration in comparison with oral post-reperfusion-metoprolol or placebo. We also studied the effect on suspected markers of reperfusion injury.
METHODS: Thirty Yorkshire-pigs underwent a reperfused myocardial infarction, being randomized to pre-reperfusion-metoprolol, post-reperfusion-metoprolol or placebo. Cardiac magnetic resonance imaging was performed in eighteen pigs at day 3 for the quantification of salvaged myocardium. The amounts of at-risk and infarcted myocardium were quantified using T2-weighted and post-contrast delayed enhancement imaging, respectively. Twelve animals were sacrificed after 24h for reperfusion injury analysis.
RESULTS: The pre-reperfusion-metoprolol group had significantly larger salvaged myocardium than the post-reperfusion-metoprolol or the placebo groups (31 ± 4%, 13 ± 6%, and 7 ± 3% of myocardium at-risk respectively). Post-mortem analyses suggest lesser myocardial reperfusion injury in the pre-reperfusion-metoprolol in comparison with the other 2 groups (lower neutrophil infiltration, decreased myocardial apoptosis, and higher activation of the salvage-kinase phospho-Akt). Salvaged myocardium and reperfusion injury pair wise comparisons proved there were significant differences between the pre-reperfusion-metoprolol and the other 2 groups, but not among the latter two.
CONCLUSIONS: The intravenous administration of metoprolol before coronary reperfusion results in larger myocardial salvage than its oral administration initiated early after reperfusion. If confirmed in the clinical setting, the timing and route of β-blocker initiation could be revisited.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913314      PMCID: PMC3746967          DOI: 10.1016/j.ijcard.2009.09.551

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  30 in total

1.  Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.

Authors:  Amir Halkin; Cindy L Grines; David A Cox; Eulogio Garcia; Roxana Mehran; James E Tcheng; John J Griffin; Giulio Guagliumi; Bruce Brodie; Mark Turco; Barry D Rutherford; Eve Aymong; Alexandra J Lansky; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

2.  Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear.

Authors:  N B Vedder; R K Winn; C L Rice; E Y Chi; K E Arfors; J M Harlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol.

Authors:  T L Yue; X L Ma; X Wang; A M Romanic; G L Liu; C Louden; J L Gu; S Kumar; G Poste; R R Ruffolo; G Z Feuerstein
Journal:  Circ Res       Date:  1998-02-09       Impact factor: 17.367

4.  The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.

Authors:  K A Reimer; J E Lowe; M M Rasmussen; R B Jennings
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

5.  Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion.

Authors:  D García-Dorado; J Oliveras; J Gili; E Sanz; F Pérez-Villa; J Barrabés; M J Carreras; J Solares; J Soler-Soler
Journal:  Cardiovasc Res       Date:  1993-08       Impact factor: 10.787

6.  Progressively developed myocardial apoptotic cell death during late phase of reperfusion.

Authors:  Z Q Zhao; D A Velez; N P Wang; K O Hewan-Lowe; M Nakamura; R A Guyton; J Vinten-Johansen
Journal:  Apoptosis       Date:  2001-08       Impact factor: 4.677

7.  Beta-adrenergic receptor blockade modulates Bcl-X(S) expression and reduces apoptosis in failing myocardium.

Authors:  Sumanth D Prabhu; Guangwu Wang; Jianzhu Luo; Yan Gu; Peipei Ping; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2003-05       Impact factor: 5.000

8.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

Review 9.  Cardiac protection during acute myocardial infarction: where do we stand in 2004?

Authors:  Robert A Kloner; Shereif H Rezkalla
Journal:  J Am Coll Cardiol       Date:  2004-07-21       Impact factor: 24.094

Review 10.  New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

View more
  13 in total

1.  Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.

Authors:  Saurav Chatterjee; Debanik Chaudhuri; Rajesh Vedanthan; Valentin Fuster; Borja Ibanez; Sripal Bangalore; Debabrata Mukherjee
Journal:  Int J Cardiol       Date:  2012-11-17       Impact factor: 4.164

Review 2.  Top 10 cardiovascular therapies and interventions for the next decade.

Authors:  Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

Review 3.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

4.  Stimulation of the Beta2 Adrenergic Receptor at Reperfusion Limits Myocardial Reperfusion Injury via an Interleukin-10-Dependent Anti-Inflammatory Pathway in the Spleen.

Authors:  Yikui Tian; Bin Miao; Eric J Charles; Di Wu; Irving L Kron; Brent A French; Zequan Yang
Journal:  Circ J       Date:  2018-08-28       Impact factor: 2.993

5.  Early donepezil monotherapy or combination with metoprolol significantly prevents subsequent chronic heart failure in rats with reperfused myocardial infarction.

Authors:  Meihua Li; Can Zheng; Toru Kawada; Kazunori Uemura; Masashi Inagaki; Keita Saku; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2022-06-20       Impact factor: 2.781

Review 6.  Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Russel J Reiter
Journal:  World J Cardiol       Date:  2014-03-26

Review 7.  ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies.

Authors:  Sandrine Lecour; Hans E Bøtker; Gianluigi Condorelli; Sean M Davidson; David Garcia-Dorado; Felix B Engel; Peter Ferdinandy; Gerd Heusch; Rosalinda Madonna; Michel Ovize; Marisol Ruiz-Meana; Rainer Schulz; Joost P G Sluijter; Linda W Van Laake; Derek M Yellon; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2014-10-24       Impact factor: 10.787

8.  Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: new insights from a comprehensive translational study.

Authors:  Rodrigo Fernández-Jiménez; Jacobo Silva; Sara Martínez-Martínez; M Dolores López-Maderuelo; Mario Nuno-Ayala; José Manuel García-Ruiz; Ana García-Álvarez; Leticia Fernández-Friera; Tech Gonzalo Pizarro; Jaime García-Prieto; David Sanz-Rosa; Gonzalo López-Martin; Antonio Fernández-Ortiz; Carlos Macaya; Valentin Fuster; Juan Miguel Redondo; Borja Ibanez
Journal:  J Am Heart Assoc       Date:  2015-01-21       Impact factor: 5.501

9.  Neutrophil stunning by metoprolol reduces infarct size.

Authors:  Jaime García-Prieto; Rocío Villena-Gutiérrez; Mónica Gómez; Esther Bernardo; Andrés Pun-García; Inés García-Lunar; Georgiana Crainiciuc; Rodrigo Fernández-Jiménez; Vinatha Sreeramkumar; Rafael Bourio-Martínez; José M García-Ruiz; Alfonso Serrano Del Valle; David Sanz-Rosa; Gonzalo Pizarro; Antonio Fernández-Ortiz; Andrés Hidalgo; Valentín Fuster; Borja Ibanez
Journal:  Nat Commun       Date:  2017-04-18       Impact factor: 14.919

10.  Protective approaches against myocardial ischemia reperfusion injury.

Authors:  Xianchi Li; Min Liu; Rongrong Sun; Yi Zeng; Shuang Chen; Peiying Zhang
Journal:  Exp Ther Med       Date:  2016-11-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.